Latest Headlines
-
CloudCath Receives FDA Clearance For Novel Peritoneal Dialysis (PD) At-Home Patient Monitoring System
2/15/2022
CloudCath Inc., a private medical device company advancing real-time fluid analytics and remote monitoring of infectious diseases, announced today it received U.S. Food and Drug Administration (FDA) clearance for the CloudCath System, the world's first data-driven, cloud-based, remote monitoring platform for PD patients in the $74.5B end-stage renal disease (ESRD) market1.
-
Therap Introduces A New Electronic Visit Verification (EVV) Aggregator Interface In California For In-Home And Community-Based Assistance From Service Providers In Compliance With The 21st Century Cures Act
2/10/2022
Therap Services, the leading Software as a Service solution, has been providing data-driven solutions and HIPAA-compliant electronic documentation solutions for service providers delivering In-Home Supportive Services (IHSS), Waiver Personal Care Services (WPCS) and other human services settings, is pleased to announce the interfacing with a new Electronic Visit Verification (EVV) aggregator for service providers providing personal care services and home health care services under the Medi-Cal State Plan and various Medicaid Home and Community-Based Service waiver programs in California.
-
Biofourmis Expands Into Virtual Specialty Care With The Launch Of Biofourmis Care
2/9/2022
Biofourmis, a Boston-based global leader in virtual care and digital therapeutics, announced today the launch of Biofourmis Care, a first of its kind, technology-enabled care management service that delivers high-quality remote care for patients with chronic conditions.
-
Telemedicine Company SwiftMD Announces New Site And Telehealth App
1/26/2022
SwiftMD, a telehealth company with the highest utilization rate in the industry, announced today the launch of its newly designed website, SwiftMD.com, and telehealth app as part of a brand refresh.
-
Philips Introduces First At-Home, 12-Lead ECG Integrated Solution For Decentralized Clinical Trials
1/26/2022
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the introduction of the industry’s first full-service, at-home, 12-lead electrocardiogram (ECG) solution for use in decentralized clinical trials.
-
Global Wellness Apps Launches Diabetes Focused Telehealth: DiaStrong
1/25/2022
Global Wellness Apps Inc ("GWA"), an exciting start-up venture that is poised to disrupt the manner in which diabetes and prediabetes is approached, is excited to announce that DiaStrong Health has officially launched and is now available across North America
-
OSF Healthcare Announces New Partnership For Hospital At Home Service
1/24/2022
OSF HealthCare is partnering with Medically Home Group, Inc. to establish an Acute Care at Home Program, which will enable Peoria-based OSF HealthCare to provide hospital-level, high-acuity care to patients in the comfort and convenience of their own homes.
-
Trailblazing Telemedicine Provider CallonDoc Makes Access To Affordable Healthcare Easier With At-Home Test Kits And Free Delivery
1/24/2022
CallonDoc, a healthcare provider that gives patients the ability to consult with experienced doctors from the comfort of their own homes, now offers at-home testing kits with free front-door delivery.
-
PFAS Exposure™, The First At-Home Blood Test To Detect And Measure 40+ PFAS Compounds, Now Available Nationally From empowerDX
1/21/2022
PFAS Exposure™, the first at-home test to determine levels of PFAS in a person’s blood and measure 47 of these PFAS “forever chemical” compounds, is now available from empowerDX, a leading online health and wellness resource for a wide variety of at-home health testing.
-
Axxess Partners With Two Organizations To Advance The Best Possible Value-Based Care
1/20/2022
Axxess, the leading technology innovator for care in the home, is helping home health providers deliver the best possible value-based care by partnering with aging-in-place specialist Seniors Home Services and joining the HomesRenewed Coalition.